跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 6,225 条关于
“BEAM-304”
全部
6,225
临床试验
3,394
药物
2,094
机构
15
资讯
722
3个月前
Beam Therapeutics Receives FDA Clearance for BEAM-304, a First-in-Class In Vivo Base Editing Therapy for Phenylketonuria
去年
Beam Therapeutics Reports Breakthrough in Alpha-1 Antitrypsin Deficiency Treatment with BEAM-302 Base Editing Therapy
去年
Beam Therapeutics Receives FDA Orphan Drug Designation for BEAM-101 Sickle Cell Disease Therapy
8个月前
Beam Therapeutics Secures FDA Accelerated Approval Pathway for BEAM-302 and Plans BLA Submission for Risto-cel by Year-End 2026
去年
Beam Therapeutics to Present Updated BEAM-101 Data from 17 Sickle Cell Disease Patients at EHA 2025
去年
Beam Therapeutics' BEAM-101 Shows Promise in Sickle Cell Disease Trial
去年
Mercy Expands Cancer Treatment Options with Proton Beam Therapy Clinical Trials
去年
Beam Therapeutics Reports Patient Death in BEAM-101 Sickle Cell Disease Trial
去年
Patient Death in Beam Therapeutics' Sickle Cell Trial Linked to Conditioning Regimen
去年
Beam Therapeutics' ESCAPE Platform Shows Promise in Non-Genotoxic Conditioning for Sickle Cell Disease
第 1 页,共 73 页
上一页
下一页